Related Experiment Video
Updated: Apr 20, 2026
02:28
Author Spotlight: Self-Assessment Protocol for Predicting Psoriatic Arthritis in Psoriasis Patients
Published on: March 1, 2024
1.0K
Psoriatic arthritis for the dermatologist
Suzanne J Tintle1, Alice B Gottlieb1
1Department of Dermatology, Tufts Medical Center, 800 Washington Street, Box #114, Boston, MA 02111, USA.
Dermatologic Clinics
|November 22, 2014
Summary
Psoriatic arthritis (PsA) is a common, disabling condition affecting psoriasis patients. Early recognition and aggressive management by dermatologists are crucial to halt disease progression and prevent disability.
Area of Science:
- Rheumatology
- Dermatology
Background:
- Psoriatic arthritis (PsA) is a chronic, progressive inflammatory disease.
- It affects about one-third of individuals with psoriasis.
- Dermatologists play a key role in early PsA detection and management.
Purpose of the Study:
- To emphasize the dermatologist's role in managing psoriatic arthritis.
- To highlight the need for aggressive treatment in moderate-to-severe cases.
- To review available medications for PsA, considering safety, efficacy, and cost.
Main Methods:
- Review of current literature on psoriatic arthritis management.
- Analysis of treatment options for moderate-to-severe PsA.
- Evaluation of medication profiles including safety, tolerability, efficacy, and cost.
Main Results:
- Early recognition of PsA by dermatologists is vital.
- Aggressive immunosuppressive therapy is required for moderate-to-severe PsA.
- Understanding medication characteristics is essential for effective disease control.
Conclusions:
- Dermatologists are uniquely positioned to manage PsA.
- Effective management can halt disease progression and prevent disability.
- Comprehensive understanding of treatment options is necessary for optimal patient outcomes.
